A Merck investment subsidiary was among the backers for the $9.3m round, which follows a $300,000 equity investment in 2009.

MedCPU, a US-based developer of real-time healthcare decision support systems, has secured $9.3m in series B financing from investors including pharmaceutical company Merck.

Founded in 2009, MedCPU’s Advisor technology analyses information from Electronic Medical Records, matching it to best-practice data to devise real-time prompts advising treatments for each patient.

Merck Global Health Innovation Fund invested alongside Easton Capital Investment Group and New Richmond Ventures. MedCPU previously raised $1.3m in convertible debt financing 2011 and $300,000 in equity in 2009, according…